Pizcueta MP - Search Results

1

Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.

Kravetz D, Bosch J, Arderiu MT, Pizcueta MP, Casamitjana R, Rivera F, Rodés J. Kravetz D, et al. Among authors: pizcueta mp. Am J Physiol. 1988 Mar;254(3 Pt 1):G322-8. doi: 10.1152/ajpgi.1988.254.3.G322. Am J Physiol. 1988. PMID: 2894777

2

Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension.

Pizcueta MP, Piqué JM, Bosch J, Whittle BJ, Moncada S. Pizcueta MP, et al. Br J Pharmacol. 1992 Jan;105(1):184-90. doi: 10.1111/j.1476-5381.1992.tb14233.x. Br J Pharmacol. 1992. PMID: 1596680 Free PMC article.

3

Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.

Pizcueta MP, García-Pagán JC, Fernández M, Casamitjana R, Bosch J, Rodés J. Pizcueta MP, et al. Gastroenterology. 1991 Dec;101(6):1710-5. doi: 10.1016/0016-5085(91)90411-d. Gastroenterology. 1991. PMID: 1683327

4

Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.

Ruiz del Arbol L, García-Pagán JC, Feu F, Pizcueta MP, Bosch J, Rodés J. Ruiz del Arbol L, et al. Among authors: pizcueta mp. J Hepatol. 1991 Sep;13(2):179-86. doi: 10.1016/0168-8278(91)90812-p. J Hepatol. 1991. PMID: 1744422 Clinical Trial.

5

Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.

Nevens F, Pizcueta MP, Fernández M, Bosch J, Rodés J. Nevens F, et al. Among authors: pizcueta mp. Hepatology. 1991 Dec;14(6):1174-8. Hepatology. 1991. PMID: 1959867

6

Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism.

Pizcueta MP, Casamitjana R, Bosch J, Rodés J. Pizcueta MP, et al. Am J Physiol. 1990 Feb;258(2 Pt 1):G191-5. doi: 10.1152/ajpgi.1990.258.2.G191. Am J Physiol. 1990. PMID: 2305884

7

Evaluation of the portal hypertensive patient.

Bosch J, Pagán JC, Bruix J, Ruiz del Arbol L, Pizcueta MP, Navasa M, Feu F, Bru C, Rodés J. Bosch J, et al. Among authors: pizcueta mp. J Gastroenterol Hepatol. 1989;4 Suppl 1:39-47. J Gastroenterol Hepatol. 1989. PMID: 2519083 Review.

8

Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.

Pizcueta MP, de Lacy AM, Kravetz D, Bosch J, Rodés J. Pizcueta MP, et al. Hepatology. 1989 Dec;10(6):953-7. doi: 10.1002/hep.1840100610. Hepatology. 1989. PMID: 2583690

9

Diagnosis and evaluation of portal hypertension.

Bosch J, Navasa M, Kravetz D, Pizcueta MP, García-Pagán JC, De Lacy AM, Rodés J. Bosch J, et al. Among authors: pizcueta mp. Z Gastroenterol. 1988 Sep;26 Suppl 2:8-14. Z Gastroenterol. 1988. PMID: 3055719 Review.

10

Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: comparison with the effects on portal pressure.

Bosch J, Bordas JM, Mastai R, Kravetz D, Navasa M, Chesta J, Pizcueta MP, García-Pagán JC, Rodés J. Bosch J, et al. Among authors: pizcueta mp. Hepatology. 1988 Jul-Aug;8(4):861-5. doi: 10.1002/hep.1840080427. Hepatology. 1988. PMID: 3391513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters